Share

April 12, 2011; 76 (15) Articles

Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab

H.L. Pellkofer, M. Krumbholz, A. Berthele, B. Hemmer, L.A. Gerdes, J. Havla, R. Bittner, M. Canis, E. Meinl, R. Hohlfeld, T. Kuempfel
First published April 11, 2011, DOI: https://doi.org/10.1212/WNL.0b013e3182152881
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1203

Share

Article Information

vol. 76 no. 15 1310-1315
DOI: 
https://doi.org/10.1212/WNL.0b013e3182152881
PubMed: 
21482945
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received September 2, 2010
  • Accepted January 3, 2011
  • First Published April 11, 2011.
Copyright & Usage: 
Copyright © 2011 by AAN Enterprises, Inc.

Author Disclosures

    1. H.L. Pellkofer, MD,
    2. M. Krumbholz, MD,
    3. A. Berthele, MD,
    4. B. Hemmer, MD,
    5. L.A. Gerdes, MD,
    6. J. Havla, MD,
    7. R. Bittner,
    8. M. Canis, MD,
    9. E. Meinl, MD,
    10. R. Hohlfeld, MD and
    11. T. Kuempfel, MD
  1. H.L. Pellkofer, MD,
  2. M. Krumbholz, MD,
  3. A. Berthele, MD,
  4. B. Hemmer, MD,
  5. L.A. Gerdes, MD,
  6. J. Havla, MD,
  7. R. Bittner,
  8. M. Canis, MD,
  9. E. Meinl, MD,
  10. R. Hohlfeld, MD and
  11. T. Kuempfel, MD
  1. From the Institute for Clinical Neuroimmunology (H.L.P., M.K., L.A.G., J.H., R.B., E.M., R.H., T.K.), Department of Neurology (H.L.P.), and Department of Otorhinolaryngology, Head and Neck Surgery (M.C.), Ludwig Maximilians University, Munich; Department of Neuroimmunology (M.K., R.B., E.M.), Max-Planck Institute for Neurobiology, Martinsried; and Department of Neurology (A.B., B.H.), Technische Universität, Munich, Germany.
  1. Address correspondence and reprint requests to Dr. Hannah Pellkofer, Institute of Clinical Neuroimmunology, Ludwig Maximilians University, D-81377 Munich, Germany hannah.pellkofer{at}med.uni-muenchen.de
View Full Text

Article usage

Article usage: April 2011 to May 2020

AbstractFullPdfSource
Apr 20111571138212Highwire
May 201135599117Highwire
Jun 20112507071Highwire
Jul 20111735353Highwire
Aug 2011822619Highwire
Sep 20111093939Highwire
Oct 2011842824Highwire
Nov 2011742218Highwire
Dec 2011641720Highwire
Jan 20121062226Highwire
Feb 2012862518Highwire
Mar 20121031815Highwire
Apr 2012821117Highwire
May 201299312Highwire
Jun 20121001314Highwire
Jul 201289412Highwire
Aug 201269715Highwire
Sep 2012721715Highwire
Oct 201281514Highwire
Nov 201291811Highwire
Dec 20126287Highwire
Jan 2013841011Highwire
Feb 2013761013Highwire
Mar 20136658Highwire
Apr 2013841511Highwire
May 201385128Highwire
Jun 20136368Highwire
Jul 201354105Highwire
Aug 20135459Highwire
Sep 201351118Highwire
Oct 201350910Highwire
Nov 20137458Highwire
Dec 20135767Highwire
Jan 20145257Highwire
Feb 201463811Highwire
Mar 20145724Highwire
Apr 20143164Highwire
May 201458910Highwire
Jun 201459135Highwire
Jul 20147434Highwire
Aug 20146787Highwire
Sep 20144245Highwire
Oct 20145857Highwire
Nov 20146667Highwire
Dec 20145662Highwire
Jan 20154268Highwire
Feb 20153687Highwire
Mar 20155448Highwire
Apr 20152366Highwire
May 20155166Highwire
Jun 20155825Highwire
Jul 20154266Highwire
Aug 201565911Highwire
Sep 20154458Highwire
Oct 20157172Highwire
Nov 201557815Highwire
Dec 20155222Highwire
Jan 201658115Highwire
Feb 20165323Highwire
Mar 20165815Highwire
Apr 20164235Highwire
May 20164221Highwire
Jun 20163252Highwire
Jul 20164333Highwire
Aug 20164921Highwire
Sep 20163422Highwire
Oct 20164063Highwire
Nov 20163566Highwire
Dec 20163100Highwire
Jan 20174111Highwire
Feb 20173155Highwire
Mar 20175356Highwire
Apr 201733104Highwire
May 20172213Highwire
Jun 20172733Highwire
Jul 20173155Highwire
Aug 20173252Highwire
Sep 20173457Highwire
Oct 20172421Highwire
Nov 20172744Highwire
Dec 20173352Highwire
Jan 201812722Highwire
Feb 201843134Highwire
Mar 20186883Highwire
Apr 20184396Highwire
May 20184884Highwire
Jun 20184000Highwire
Jul 20185424Highwire
Aug 20185634Highwire
Sep 20184823Highwire
Oct 20186433Highwire
Nov 20187487Highwire
Dec 20185331Highwire
Jan 20195589Highwire
Feb 20194633Highwire
Mar 20193775Highwire
Apr 20194045Highwire
May 20194765Highwire
Jun 20194057Highwire
Jul 20194343Highwire
Aug 20195521Highwire
Sep 20193822Highwire
Oct 20197986Highwire
Nov 20198956Highwire
Dec 20199235Highwire
Jan 20205812Highwire
Feb 20204665Highwire
Mar 20204724Highwire
Apr 20204532Highwire
May 202038101Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me